Immunis, Inc.

Strategic investments in regenerative biotech companies like Immunis are necessary for clinical innovation in the healthcare ecosystem. Check out a talk from our Sr. Scientific Researcher, Dr. Scott Greilach, to hear more about our novel multi-active biologics for age-related diseases like muscle atrophy. Also, Chief Business Officer, Mark Cabato, CFA will be in attendance to meet with any potential investors. We look forward to seeing you there!! Investival Showcase #biotech #innovation #humanhealth #regenerativemedicine

Immunis successfully completed a Phase 1/2a clinical trial for its multi-active therapy. ?? The trial tested the safety, tolerability and preliminary efficacy of IMM01-STEM in elderly individuals with muscle atrophy associated with knee osteoarthritis. We are excited to share the highlights from our trial.??? https://lnkd.in/gPDh9YrY #clinicaltrials #muscleatrophy #osteoarthritis #healthspan #sarcopenia

What is one thing that can help YOU live a longer, healthier life? At Abundance360, forward-thinking entrepreneurs, scientists, and innovators are dedicated to developing technologies that can help extend human healthspan. Our Chairman, Dr. Hans Keirstead, was an invited speaker at this year's?conference to share how Immunis' multi-active biologics are tackling muscle atrophy and metabolic decline, two of the most common age-related ailments that are exacerbated by immune dysregulation. It was an honor for our company and our Chairman to be included among the pioneers shaping the next era of medicine and biotechnology. A heartfelt thank you to?Dr. Peter H. Diamandis?for organizing this extraordinary event.?Abundance360?is more than a conference—it’s a movement that empowers leaders to drive breakthroughs in longevity, AI, and healthspan optimization. We are optimistic that the insights and collaborations formed at?Abundance360?will accelerate changes in healthcare. If you have the opportunity to attend this event, you will find yourself with a completely new perspective on how YOU can take control of your health and redefine YOUR aging journey. The future of longevity is shining with possibility and Immunis is thrilled to make it even brighter. ?? #Abundance360 #Longevity #Biotech #FutureOfHealth #ExponentialTechnologies #sarcopenia #biotech #innovation

Imagine a world where your age no longer defines your quality of life - where you have the?wisdom?of your eighties, but the?vitality?of your fifties. Where you have the?health?to continue pursuing your life’s purpose.? ? Imagine what you could be capable of. ? At Immunis, our mission is to?maximize?health and to minimize disease through the development of novel, stem cell-derived therapies. Our vision is to?reimagine aging?without the burden of age-related illnesses.? ? This is Immunis. Hans Keirstead https://lnkd.in/g-J2f4qh

Don't miss the opportunity to join us at NextMed Health March 30-April 2nd in San Diego ?? https://lnkd.in/gEYJye7f! You will get the opportunity to hear from our world-class faculty and join our interdisciplinary community dedicated to catalyzing and accelerating the arrival of a new, human-centric, technology-enabled health age. Hans Keirstead PhD, Chairman of Immunis, Inc. will be among the world-renowned faculty joining us! Dr. Keirstead is an internationally recognized stem cell expert and successful entrepreneur. Known for developing treatments for quadriplegic spinal cord injury, cancer therapies for melanoma, brain, and ovarian cancers, and a multi-pathogen vaccine, he has also advanced therapeutic research for motor neuron diseases, retinal diseases, immune disorders, and age-related immune decline. Each of Dr. Keirstead’s three prior biotechnology firms was acquired by major pharmaceutical companies for 2.5X-9.5X returns to investors, after return of investment capital. He currently holds board positions in several leading biotechs including AIVITA Biomedical, Inc. Immunis, Inc. Inc., and the global Human Immunome Project. See you in a few weeks!

?? Be part of this transformative event in San Diego and witness how technology and innovation are revolutionizing healthcare. ?? Chairman Dr. Hans Keirstead will be a featured speaker at the prestigious 2025 NextMed Health Conference! He will share the incredible pre-clinical and clinical data with our novel biologics, which are aiming to improve human healthspan. ?? ???? Register here: https://lnkd.in/gmem8An9 #NextMed2025 #InnovationInMedicine #HealthcareLeaders?#biotech #humanhealth #healthspan

???Milestone Alert??? ?? Immunis Treats its First Patients for Sarcopenic Obesity ?? ?? We are truly proud of our incredible team. We will continue to push the boundaries of therapeutics that can potentially transform human healthspan because EVERYONE deserves to live a longer, healthier life. ?? Read the full press release here: https://lnkd.in/gwmcZyjn #biotech #sarcopenia #obesity #healthspan

?? ?? Do YOU want to help drive the future of human healthspan?! ???? Immunis CBO?Mark Cabato, CFA, heads to Miami’s?Investival Showcase?to forge alliances with forward-thinking investors. Our platform leverages?stem cell-derived multi-active biologics to deliver therapies that address sarcopenia, osteoarthritis, obesity and more! ?? With 400+ attendees and tailored 1:1 sessions, this is the moment to invest in science that restores vitality. Ready to collaborate? Reach out to Mark and explore Immunis’ groundbreaking pipeline. ??Learn more about our programs:?https://lnkd.in/g_kqM-MB #BiotechNetworking #StrategicPartnerships #AgeRelatedDiseases?

It was an honor for Dr. Hans Keirstead to be included as a panelist for not one, but TWO Power Sessions at this year's Lake Nona Impact Forum.???? Session 1?? - From Genes to Defense: A Deep Dive into the Human Immunome?(Representing the Human Immunome Project) ?????? Session 2?? - Living Younger, Longer: The Science of Healthspan Optimization ??♂??? ???? (Representing Immunis, Inc.) The Lake Nona Impact Forum is an annual, invitation-only event that convenes global thought leaders, innovators, and experts in health, wellness, technology, and business to inspire collaborative solutions for the world's most challenging health issues. ??? Dr. Keirstead appreciates the opportunity to be a part of these important discussions and looks forward to catalyzing transformative therapeutics that can enhance quality of life for all! #biotechinnovation #longevity #healthspan

?? ?? ?? Opportunity meets innovation! Immunis is thrilled to join industry leaders at?the Investival Showcase USA, where CBO?Mark Cabato, CFA, will highlight our pipeline of?all-human, naturally derived biologics?for age-related diseases. We’re poised to attract strategic investors aligned with our mission to combat age-related muscle loss (sarcopenia). ?? Connect with Mark in Miami and together, we can turn clinical-stage therapeutics into real-world impact. #muscleloss #sarcopenia #noveltherapies #HealthcareInvesting #BiotechShowcase #NextGenTherapeutics